Index

Rufinamid

Substansgruppe(r) Antiepileptika
Salgsnavn Inovelon
ATC-kode N03AF03
CAS-nummer 106308-44-5
Molekylvekt 238,19
Biotilgjengelighet >85 %
Tmax 3,4-8 timer
Proteinbinding 26-35 % (mest til albumin)
Distribusjonsvolum 0,8-1,2 liter/kg
Blod/plasma-ratio 1,0
Halveringstid 5-11 timer
Referanseområde 15 – 130 μmol/L
Rufinamid2

Referanser

Randall Baselt: Disposition of toxic drugs and chemicals in man, tenth edition.

Perucca E, Cloyd J, Critchley D, Fuseau E. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia 2008; 49:1123–41.

May TW, Boor R, Rambeck B, Jürgens U, Korn-Merker E, Brandt C. Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication. Ther Drug Monit. 2011 Apr;33(2):214-21.

PubChem


Sist oppdatert 29. april 2020

Tilgjengelige analyser

Plasma/Serum

Analysenavn Metode Laboratorium Mer info
Rufinamid LC-MS/MS Klinisk farmakologi St Olav (St Olavs hospital) Mer info
Rufinamid LC-MS/MS Klinisk farmakologi Haukeland (Helse Bergen) Mer info
Rufinamid LC-MS/MS Klinisk farmakologi OUS Spesialsykehuset for epilepsi (SSE) (Oslo universitetssykehus) Mer info

Fullblod

Analysenavn Metode Laboratorium Mer info
Rufinamid LC-MS/MS Klinisk farmakologi St Olav (St Olavs hospital) Mer info